Thomas Hancock Net Worth

Thomas Hancock biography

Thomas E. Hancock serves as Independent Director of the Company. He has over fifteen years of experience in the biopharmaceutical industry and equity capital markets. Since September 2004, he has been the Principal of Nexus Medical Partners, where he has been responsible for several investments, including A&G Pharmaceuticals Inc., Magellan Biosciences, Inc., and Panacos Pharmaceuticals, Inc. and a principal of Nexus Investment Company, a FINRA member. Prior to joining Nexus Medical Partners, Mr. Hancock was a Senior Equity Analyst and Managing Director at US Bancorp Piper Jaffray, covering both the biopharmaceutical and drug discovery tools markets. He has also held numerous positions at Genentech, Inc. and COR Therapeutics, Inc. Mr. Hancock has a BS in Molecular Biology and an MBA from UC Berkeley.

What is the salary of Thomas Hancock?

As the Independent Director of AB Active ETFs Inc, the total compensation of Thomas Hancock at AB Active ETFs Inc is $61,895. There are 5 executives at AB Active ETFs Inc getting paid more, with Stephen From having the highest compensation of $601,340.

How old is Thomas Hancock?

Thomas Hancock is 56, he's been the Independent Director of AB Active ETFs Inc since 2007. There are 5 older and 3 younger executives at AB Active ETFs Inc. The oldest executive at AB Active ETFs Inc is Morton Goldberg, 82, who is the Independent Director.

What's Thomas Hancock's mailing address?

Thomas's mailing address filed with the SEC is C/O EYEGATE PHARMACEUTICALS, INC., 271 WAVERLEY OAKS ROAD, SUITE 108, WALTHAM, MA, 02452.

Insiders trading at AB Active ETFs Inc

Over the last 10 years, insiders at AB Active ETFs Inc have traded over $15,523,641 worth of AB Active ETFs Inc stock and bought 17,254,349 units worth $18,625,708 . The most active insiders traders include Capital, Llc Armistice Capi..., Peter Greenleaf, and (Innoven Partenaires S.A.) .... On average, AB Active ETFs Inc executives and independent directors trade stock every 60 days with the average trade being worth of $19,985,138. The most recent stock trade was executed by Capital, Llc Armistice Capi... on 30 July 2021, trading 260,963 units of EYEG stock currently worth $647,188.

What does AB Active ETFs Inc do?

AB Active ETFs Inc executives and stock owners

AB Active ETFs Inc executives and other stock owners filed with the SEC include:

• Stephen From,
  President, Chief Executive Officer, Director
• Michael Manzo,
  Vice President - Engineering
• Sarah Romano,
  Chief Financial Officer
• Paul Chaney,
  Independent Chairman of the Board
• Praveen Tyle,
  Independent Director
• Thomas Hancock,
  Independent Director
• Bernard Malfroy-Camine,
  Independent Director
• Morton Goldberg,
  Independent Director
• Keith Maher,
  Director
• Steven Boyd,
  Director
• Brenda Mann,
  VP of Research & Development
• Michael Garanzini,
  Chief Commercial Officer
• Peter Greenleaf,
  Director
• Barbara Wirostko,
  Chief Medical Officer
• (Innoven Partenaires S.A.) ...,
  10% owner
• Private Equity Natixis,
  10% owner
• Thomas Balland,
  Director
• Ventech B Fcpr,
  10% owner
• Capital Ii Ventech,
  10% owner
• Mounia Chaoui,
  Director
• Ryan Randall Brenneman,
  Chief Financial Officer
• Franz Obermayr,
  Acting CEO
• Kenneth L Gayron,
  Director
• Aron Shapiro,
  Director
• Brian M. Strem,
  President and CEO